Verona Pharma Plc Stock Market Value

VRNA Stock  USD 22.95  0.37  1.64%   
Verona Pharma's market value is the price at which a share of Verona Pharma trades on a public exchange. It measures the collective expectations of Verona Pharma PLC investors about its performance. Verona Pharma is trading at 22.95 as of the 21st of July 2024, a 1.64% increase since the beginning of the trading day. The stock's open price was 22.58.
With this module, you can estimate the performance of a buy and hold strategy of Verona Pharma PLC and determine expected loss or profit from investing in Verona Pharma over a given investment horizon. Check out Verona Pharma Correlation, Verona Pharma Volatility and Verona Pharma Alpha and Beta module to complement your research on Verona Pharma.
Symbol

Verona Pharma PLC Price To Book Ratio

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verona Pharma. If investors know Verona will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verona Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.80)
Revenue Per Share
0.006
Return On Assets
(0.15)
Return On Equity
(0.25)
The market value of Verona Pharma PLC is measured differently than its book value, which is the value of Verona that is recorded on the company's balance sheet. Investors also form their own opinion of Verona Pharma's value that differs from its market value or its book value, called intrinsic value, which is Verona Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verona Pharma's market value can be influenced by many factors that don't directly affect Verona Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verona Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verona Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verona Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Verona Pharma 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Verona Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Verona Pharma.
0.00
06/21/2024
No Change 0.00  0.0 
In 30 days
07/21/2024
0.00
If you would invest  0.00  in Verona Pharma on June 21, 2024 and sell it all today you would earn a total of 0.00 from holding Verona Pharma PLC or generate 0.0% return on investment in Verona Pharma over 30 days. Verona Pharma is related to or competes with Arcellx, Immunocore Holdings, Vaxcyte, Nuvalent, Cerevel Therapeutics, Travere Therapeutics, and Structure Therapeutics. Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies... More

Verona Pharma Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Verona Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Verona Pharma PLC upside and downside potential and time the market with a certain degree of confidence.

Verona Pharma Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Verona Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Verona Pharma's standard deviation. In reality, there are many statistical measures that can use Verona Pharma historical prices to predict the future Verona Pharma's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Verona Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
18.2022.5426.88
Details
Intrinsic
Valuation
LowRealHigh
22.9027.2431.58
Details
6 Analysts
Consensus
LowTargetHigh
30.1633.1436.79
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.39-0.37-0.05
Details

Verona Pharma PLC Backtested Returns

Verona Pharma appears to be not too volatile, given 3 months investment horizon. Verona Pharma PLC owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.16, which indicates the firm had a 0.16% return per unit of risk over the last 3 months. By inspecting Verona Pharma's technical indicators, you can evaluate if the expected return of 0.69% is justified by implied risk. Please review Verona Pharma's Coefficient Of Variation of 693.55, risk adjusted performance of 0.1009, and Semi Deviation of 2.82 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Verona Pharma holds a performance score of 12. The entity has a beta of 1.45, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Verona Pharma will likely underperform. Please check Verona Pharma's skewness, and the relationship between the potential upside and rate of daily change , to make a quick decision on whether Verona Pharma's existing price patterns will revert.

Auto-correlation

    
  0.38  

Below average predictability

Verona Pharma PLC has below average predictability. Overlapping area represents the amount of predictability between Verona Pharma time series from 21st of June 2024 to 6th of July 2024 and 6th of July 2024 to 21st of July 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Verona Pharma PLC price movement. The serial correlation of 0.38 indicates that just about 38.0% of current Verona Pharma price fluctuation can be explain by its past prices.
Correlation Coefficient0.38
Spearman Rank Test0.58
Residual Average0.0
Price Variance5.1

Verona Pharma PLC lagged returns against current returns

Autocorrelation, which is Verona Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Verona Pharma's stock expected returns. We can calculate the autocorrelation of Verona Pharma returns to help us make a trade decision. For example, suppose you find that Verona Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Verona Pharma regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Verona Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Verona Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Verona Pharma stock over time.
   Current vs Lagged Prices   
       Timeline  

Verona Pharma Lagged Returns

When evaluating Verona Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Verona Pharma stock have on its future price. Verona Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Verona Pharma autocorrelation shows the relationship between Verona Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Verona Pharma PLC.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Information and Resources on Investing in Verona Stock

When determining whether Verona Pharma PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Verona Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Verona Pharma Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Verona Pharma Plc Stock:
Check out Verona Pharma Correlation, Verona Pharma Volatility and Verona Pharma Alpha and Beta module to complement your research on Verona Pharma.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Verona Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Verona Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Verona Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...